旭輝(00884.HK)11月合約銷售256.5億,前11月累計已破兩千億
格隆匯12月7日丨旭輝控股集團(00884.HK)發佈11月銷售業績公告,公司11月單月實現合約銷售256.5億元,同比增長16%,合約銷售面積約1,608,600萬平方米,合約銷售均價為15,900元/平方米。在今年房地產行業普遍受到疫情衝擊的背景下,旭輝仍保持了穩健的銷售增長,尤其在下半年實現快速反彈。1-11月,公司累計實現合約銷售2000.2億元,同比增長13%。累計合約銷售面積約13,180,800平方米。此前,旭輝控股董事局主席林中曾在中期業績會上表示,公司下半年可推售貨值最多可達2800億,新推項目超過50個。在持續穩定的供貨與有序的營銷節奏下,旭輝12月業績或將更進一步,以支撐2300億的全年銷售目標的達成。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.